Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Przemysław R. Kac(University of Gothenburg), Thomas K. Karikari(University of Pittsburgh), Kaj Blennow(Sahlgrenska University Hospital), Fernando González‐Ortiz(Sahlgrenska University Hospital), Nele Dewit(Ablynx (Belgium)), Eugeen Vanmechelen(ADx NeuroSciences), Nicholas J. Ashton(King's College London), Henrik Zetterberg(University of Wisconsin–Madison), Joel Simrén(University of Gothenburg)
Cited by 71
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k